WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , IFSIJ Measure of Journal Quality , Scientific Journal Impact Factor (SJIF) , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , 

ISSN 2457-0400

Impact Factor  :  6.711

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • 6th International Conference on Human and Soci

    Venue:FCT Education Resource Center, Abuja- Nigeria                                        September 22-24, 2019

  • .

    6th INTERNATIONAL CONFERENCE ON EDUCATIONAL TECHNOLOGY AND CURRICULUM STUDIES(ICETC2019) 

     

    Venue: FCT Education Resource Center, Abuja-Nigeria

    September 22-24, 2019

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased to 6.711 for Year 2024.

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR March 2023 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

  • WJAHR: MARCH ISSUE PUBLISHED

    March 2024 Issue has been successfully launched on 1 March 2024.

Best Paper Awards

World Journal of Advance Healthcare Research (WJAHR)Honored the authors with best paper award, monthly based on the innovation of research work. Best paper will be selected by our expert panel.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

THE RATE 0F EXCHANGE TRANSFUSION PRE AND POST USE OF INTENSIVE PHOTOTHERAPY

Dr. Firas Salam Fakhri*, Dr. Teba Kasim Mohamed and Ali Hussein AL-Faydawi

ABSTRACT

Introduction: Hyperbilirubinemia is a prevalent and generally harmless condition in newborns. Around 60% of full-term infants and 80% of preterm infants experience jaundice in their first week of life. However, hyperbilirubinemia can cause encephalopathy at any point during the neonatal period, with lethargy, poor feeding, and loss of the Moro reflex being common early signs. Objectives: This study aims to evaluate the efficacy of intensive phototherapy in reducing the need for exchange transfusion at AL-Zahraa Teaching Hospital in AL-Najaf city. Method: This retrospective study analyzed 6528 full-term infants with indirect hyperbilirubinemia at Al-Zahraa Teaching Hospital between 2008 and 2011. Exclusions comprised premature newborns, direct hyperbilirubinemia cases, critically ill newborns, and others. The research compared the need for ECT between two periods: 2008-2009 (no IPT) and 2010-2011 (IPT as an alternative). The American Academy of Pediatrics (AAP) guidelines were followed for managing hyperbilirubinemia in the neonatal care unit. Results: The study of 6528 neonates with neonatal jaundice revealed a significant decrease in exchange transfusion (ECT) rates from 668 cases (2008-2009) to 75 cases (2010-2011) following the implementation of intensive phototherapy (IPT), resulting in a 90% reduction. Males were more affected than females. The main cause of hyperbilirubinemia necessitating ECT was ABO incompatibility, followed by Rh incompatibility and other causes, with similar patterns observed in both study periods. Conclusion: In conclusion, extensive phototherapy is more effective in reducing excessive bilirubin levels in all types of newborn jaundice, particularly in cases of Rh and ABO incompatibility. Consequently, highly intensive phototherapy for neonatal jaundice lowered the exchange transfusion rate and associated complications.

[Full Text Article] [Download Certificate]